Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:administeredBy |
injection
|
| gptkbp:approvedBy |
gptkb:FDA
1988 |
| gptkbp:ATCCode |
gptkb:H01CB02
|
| gptkbp:brand |
gptkb:octreotide
|
| gptkbp:contraindication |
hypersensitivity to octreotide
|
| gptkbp:form |
solution for injection
long-acting release (LAR) formulation |
| https://www.w3.org/2000/01/rdf-schema#label |
Sandostatin
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
somatostatin analog
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
nausea diarrhea abdominal pain hyperglycemia gallstones |
| gptkbp:usedFor |
gptkb:VIPomas
gptkb:carcinoid_tumors acromegaly |
| gptkbp:bfsParent |
gptkb:Novartis
|
| gptkbp:bfsLayer |
4
|